G A Patterson
Overview
Explore the profile of G A Patterson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
282
Citations
2722
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
de Perrot M, Weder W, Patterson G, Keshavjee S
Eur Respir J
. 2004 Apr;
23(3):477-82.
PMID: 15065841
A number of strategies have been advocated to increase the number of lung donors including: 1) improvement in donor resuscitation; 2) better methods of lung preservation; 3) extension of the...
22.
Parekh K, Trulock E, Patterson G
Transplant Proc
. 2004 Mar;
36(2 Suppl):318S-322S.
PMID: 15041361
Prior to the cyclosporine (CsA) era, there were no long-term survivors from lung transplantation as the immunosuppressive drugs made patients very susceptible to opportunistic infections and anastomotic complications. CsA is...
23.
Lau C, Patterson G
Eur Respir J Suppl
. 2003 Nov;
47:57s-64s.
PMID: 14621118
Two decades have passed since the first successful clinical lung transplant was performed in 1983, and, in the interim, lung transplantation has become the preferred treatment option for a variety...
24.
Meyers B, Patterson G
Thorax
. 2003 Jul;
58(7):634-8.
PMID: 12832685
There are currently three surgical treatments for emphysema: bullectomy, lung transplantation, and lung volume reduction surgery (LVRS). Unfortunately, most emphysema patients are poor candidates for any surgical intervention. A meticulous...
25.
Reznik S, Jaramillo A, SivaSai K, Womer K, Sayegh M, Trulock E, et al.
Am J Transplant
. 2002 Jul;
1(3):228-35.
PMID: 12102256
A correlation between indirect allorecognition of mismatched donor HLA class I peptides and development of bronchiolitis obliterans syndrome (BOS) after lung transplantation has been previously observed. The aim of this...
26.
Stewart K, Patterson G
Am J Transplant
. 2002 Jul;
1(3):204-10.
PMID: 12102253
Lung transplantation provides very good short- and acceptable long-term survival for patients with advanced lung disease. More widespread use of marginal and distant donors can be employed in selected recipients...
27.
Paranjothi S, Yusen R, Kraus M, Lynch J, Patterson G, Trulock E
J Heart Lung Transplant
. 2001 Oct;
20(10):1054-63.
PMID: 11595560
Background: Post-transplantation lymphoproliferative disease (PTLD) after lung transplantation has not been fully characterized. In previous studies, the incidence has varied substantially, and most cases have been reported during the first...
28.
McKane B, Trulock E, Patterson G, Mohanakumar T
Immunol Res
. 2001 Oct;
24(2):177-90.
PMID: 11594455
Major advancements in the field of lung transplantation have occurred over the past thirty-five years. Despite these advancements, limitations in our ability to obtain sufficient numbers of organs and in...
29.
Itano H, Mora B, Zhang W, Ritter J, McCarthy T, Yew N, et al.
J Thorac Cardiovasc Surg
. 2001 Jul;
122(1):29-38.
PMID: 11436034
Background: Recent studies suggest that viral interleukin 10 suppresses alloimmune response in transplantation and that cationic lipids are one of the most promising nonviral vehicles for gene therapy. The aim...
30.
Meyers B, Yusen R, Guthrie T, Davis G, Pohl M, Lefrak S, et al.
J Thorac Cardiovasc Surg
. 2001 Jul;
122(1):10-7.
PMID: 11436031
Objective: Between January 1993 and May 1998, we performed 200 consecutive bilateral lung volume reduction operations. After initial assessment, 99 of these patients were eligible for lung volume reduction and...